Ammar D. Elmezayen

Drug repurposing for coronavirus (COVID-19): <i>in silico</i> screening of known drugs against coronavirus 3CL hydrolase and protease enzymes

Ammar D. Elmezayen, Anas Al-Obaidi, Alp Tegin Şahin et al. · Journal of Biomolecular Structure and Dynamics · 2020 · 371 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Homology modeling and <i>in silico</i> design of novel and potential dual-acting inhibitors of human histone deacetylases HDAC5 and HDAC9 isozymes

Ammar D. Elmezayen, Kemal Yelekçi · Journal of Biomolecular Structure and Dynamics · 2020 · 94 citations

Life Sciences, Medicinal Chemistry, Pharmacology +16

β-Globin Mutations in Egyptian Patients With β-Thalassemia

Ammar D. Elmezayen, Samia M. Kotb, Nadia Sadek et al. · Laboratory Medicine · 2015 · 28 citations · Full text

Life Sciences, Genetics, Molecular Genetics +8

Homology modeling of human GABA-AT and devise some novel and potent inhibitors via computer-aided drug design techniques

Anas Al-Obaidi, Ammar D. Elmezayen, Kemal Yelekçi · Journal of Biomolecular Structure and Dynamics · 2020 · 28 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

SRC kinase drives multidrug resistance induced by KRAS-G12C inhibition

Xinxin Song, Zhuan Zhou, Ammar D. Elmezayen et al. · Science Advances · 2024 · 19 citations · Full text

Medicine, Oncology, Pharmacology +17